Investor FAQs

Often many questions may arise in the minds of the Investors with regard to any company. We have identified some of the possible queries and have answered them.

Corporate Profile

Thyrocare has a wholly owned subsidiary, viz. NUECLEAR HEALTHCARE LIMITED (NHL). NHL is engaged in the business of imaging diagnostic services, viz. PET-CT Scan, nuclear scanning, etc.

It has scanning centres in Navi Mumbai, New Delhi, Hyderabad, Mumbai (Prabhadevi & Borivali), Nashik, Bangalore, Surat and Vadodara.

NHL is planning to have scanning centres in more places in due course.

Thyrocare has recently acquired 51% stake in Pulse Hitech Health Services (Ghatkopar) LLP (“Pulse LLP”), which is engaged in the radiology business, such as MRI Scans, CT Scans, Ultrasonography, etc.

M/s. MSKA & Associates are the statutory auditors of the Company.

M/s. Ernst and Young are the internal auditors.

THYROCARE was founded in 1995, while THYROCARE TECHNOLOGIES LIMITED as a company was incorporated in 2000. 

Thyrocare Technologies Limited (Thyrocare) is engaged in Clinical Laboratory Services. It focuses on 1. Thyroid. 2. Metabolic Disorders. 3. Chronic Disorders. 4. Preventive care. It processes in a day 200,000 investigations and to make it simple, Thyrocare has India’s first and most advanced Totally Automated Laboratory.

  • Focus on clinical chemistry and preventive care diagnosis.
  • Air-cargo logistics, which ensure the samples reach our laboratory every night, same night, before midnight.
  • Our focused clinical laboratory works 24 x 7 to cater to the needs of our customers.
  • Total Laboratory Automation – India’s First and World’s longest automatic laboratory equipment supplied by Siemens.
  • India’s First preanalytical barcoded vial sorter (MUT) and Sample Sorter (Roche).

The Registered Office, Corporate Office and the Central Processing Laboratory of THYROCARE are located in Turbhe, Navi Mumbai, India.

Corporate Office:-
D-37/3,TTC Industrial Area,
MIDC, Turbhe,
Navi Mumbai 400 703
Tel: 91 22 2762 2762
Fax: 91 22 6778 9660
Registered Office:-
D-37/1,TTC Industrial Area,
MIDC, Turbhe,
Navi Mumbai 400 703
Tel: 91 22 2762 2762
Fax: 91 22 6778 9660


Thyrocare came out with an IPO in April 2016. The Issue was for sale of 1,07,44,708 shares by some of the existing shareholders at an issue price of Rs. 446/- including a premium of Rs. 436/-. The issue opened on April 27, 2016 and closed on April 29, 2016. The issue was oversubscribed about 75.40 times, which is the highest in the healthcare industry in India. The shares were listed on May 09, 2016 at the price of Rs. 665/-.

Thyrocare equity shares are listed in India at

National Stock Exchange (NSE: THYROCARE)


Bombay Stock Exchange (BSE: 539871)

Thyrocare ISIN code is INE594H01019.

Yes. The company has an impressive history of Bonus Issues as follows:

  • One Bonus Share for every One share held in the year 2003-04
  • Five Bonus Shares for every Two shares held in the year 2005-06
  • Three Bonus Shares for every One share held in the year 2014-15
  • 2022-23: 180%
  • 2021-22:150%
  • 2020-21: 250%
  • 2019-20: 50%
  • 2018-19: 200%
  • 2017-18: 100%
  • 2016-17: 100%
  • 2015-16: 100%

Please let us know your Folio No., old address and the new address. We will have your address changed in the relevant records and confirm it with you.

By clicking the link below, you will be able to access the Nomination Form, which you may fill up, sign and send to us. We will then have it registered in the relevant records and confirm it with you. Click Here.